Cited 0 times in
Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 고영국 | - |
dc.contributor.author | 김병극 | - |
dc.contributor.author | 김중선 | - |
dc.contributor.author | 신동호 | - |
dc.contributor.author | 안철민 | - |
dc.contributor.author | 이병권 | - |
dc.contributor.author | 이승준 | - |
dc.contributor.author | 이오현 | - |
dc.contributor.author | 이용준 | - |
dc.contributor.author | 최동훈 | - |
dc.contributor.author | 홍명기 | - |
dc.contributor.author | 홍성진 | - |
dc.contributor.author | 이상협 | - |
dc.date.accessioned | 2023-11-28T02:58:28Z | - |
dc.date.available | 2023-11-28T02:58:28Z | - |
dc.date.issued | 2023-10 | - |
dc.identifier.issn | 0002-9343 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/196717 | - |
dc.description.abstract | Background: The optimal antiplatelet therapy (APT) for patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention (PCI) is not yet established. Methods: Patients who underwent non-cardiac surgery within 1 year after second-generation drug-eluting stent implantation were included from a multicenter prospective registry in Korea. The primary endpoint was 30-day net adverse clinical event (NACE), including all-cause death, major adverse cardiovascular event (MACE), and major bleeding events. Covariate adjustment using propensity score was performed. Results: Among 1130 eligible patients, 708 (62.7%) continued APT during non-cardiac surgery. After propensity score adjustment, APT continuation was associated with a lower incidence of NACE (3.7% vs 5.5%; adjusted odds ratio [OR], 0.48; 95% confidence interval [CI], 0.26-0.89; P = .019) and MACE (1.1% vs 1.9%; adjusted OR, 0.35; 95% CI, 0.12-0.99; P = .046), whereas the incidence of major bleeding events was not different between the 2 APT strategies (1.7% vs 2.6%; adjusted OR, 0.61; 95% CI, 0.25-1.50; P = .273). Conclusions: The APT continuation strategy was chosen in a substantial proportion of patients and was associated with the benefit of potentially reducing 30-day NACE and MACE with similar incidence of major bleeding events, compared with APT discontinuation. This study suggests a possible benefit of APT continuation in non-cardiac surgery within 1 year of second-generation drug-eluting stent implantation. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Excerpta Medica | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Drug-Eluting Stents* | - |
dc.subject.MESH | Hemorrhage / chemically induced | - |
dc.subject.MESH | Hemorrhage / drug therapy | - |
dc.subject.MESH | Hemorrhage / prevention & control | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Percutaneous Coronary Intervention* / adverse effects | - |
dc.subject.MESH | Platelet Aggregation Inhibitors / therapeutic use | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sang-Hyup Lee | - |
dc.contributor.googleauthor | Choongki Kim | - |
dc.contributor.googleauthor | Sanghoon Shin | - |
dc.contributor.googleauthor | Hyeongsoo Kim | - |
dc.contributor.googleauthor | Jong-Kwan Park | - |
dc.contributor.googleauthor | Seung-Jin Oh | - |
dc.contributor.googleauthor | Sung Gyun Ahn | - |
dc.contributor.googleauthor | Sungsoo Cho | - |
dc.contributor.googleauthor | Oh-Hyun Lee | - |
dc.contributor.googleauthor | Jae Youn Moon | - |
dc.contributor.googleauthor | Hoyoun Won | - |
dc.contributor.googleauthor | Yongsung Suh | - |
dc.contributor.googleauthor | Yun-Hyeong Cho | - |
dc.contributor.googleauthor | Jung Rae Cho | - |
dc.contributor.googleauthor | Byoung-Kwon Lee | - |
dc.contributor.googleauthor | Yong-Joon Lee | - |
dc.contributor.googleauthor | Seung-Jun Lee | - |
dc.contributor.googleauthor | Sung-Jin Hong | - |
dc.contributor.googleauthor | Dong-Ho Shin | - |
dc.contributor.googleauthor | Chul-Min Ahn | - |
dc.contributor.googleauthor | Byeong-Keuk Kim | - |
dc.contributor.googleauthor | Young-Guk Ko | - |
dc.contributor.googleauthor | Donghoon Choi | - |
dc.contributor.googleauthor | Myeong-Ki Hong | - |
dc.contributor.googleauthor | Yangsoo Jang | - |
dc.contributor.googleauthor | Jung-Sun Kim | - |
dc.identifier.doi | 10.1016/j.amjmed.2023.06.003 | - |
dc.contributor.localId | A00127 | - |
dc.contributor.localId | A00493 | - |
dc.contributor.localId | A00961 | - |
dc.contributor.localId | A02097 | - |
dc.contributor.localId | A02269 | - |
dc.contributor.localId | A02793 | - |
dc.contributor.localId | A02927 | - |
dc.contributor.localId | A05164 | - |
dc.contributor.localId | A06392 | - |
dc.contributor.localId | A04053 | - |
dc.contributor.localId | A04391 | - |
dc.contributor.localId | A04403 | - |
dc.relation.journalcode | J00093 | - |
dc.identifier.eissn | 1555-7162 | - |
dc.identifier.pmid | 37356644 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S000293432300390X | - |
dc.subject.keyword | Antiplatelet therapy | - |
dc.subject.keyword | Net adverse clinical events | - |
dc.subject.keyword | Non-cardiac surgery | - |
dc.subject.keyword | Percutaneous coronary intervention | - |
dc.contributor.alternativeName | Ko, Young Guk | - |
dc.contributor.affiliatedAuthor | 고영국 | - |
dc.contributor.affiliatedAuthor | 김병극 | - |
dc.contributor.affiliatedAuthor | 김중선 | - |
dc.contributor.affiliatedAuthor | 신동호 | - |
dc.contributor.affiliatedAuthor | 안철민 | - |
dc.contributor.affiliatedAuthor | 이병권 | - |
dc.contributor.affiliatedAuthor | 이승준 | - |
dc.contributor.affiliatedAuthor | 이오현 | - |
dc.contributor.affiliatedAuthor | 이용준 | - |
dc.contributor.affiliatedAuthor | 최동훈 | - |
dc.contributor.affiliatedAuthor | 홍명기 | - |
dc.contributor.affiliatedAuthor | 홍성진 | - |
dc.citation.volume | 136 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1026 | - |
dc.citation.endPage | 1034 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF MEDICINE, Vol.136(10) : 1026-1034, 2023-10 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.